Short answer
TuHURA Biosciences, Inc./NV (HURA) filed an 8-K current report with the SEC on August 21, 2026 reporting Item 2.03 (Creation of a Direct Financial Obligation). $650,000 additional borrowing received August 20, 2026 under Parkview Holdings One LLC revolving facility.
TuHURA Biosciences, Inc./NV 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.03 · Creation of a Direct Financial Obligation
- $650,000 additional borrowing received August 20, 2026 under Parkview Holdings One LLC revolving facility
- Total facility availability capped at $50 million, maturing April 21, 2031
- Proceeds designated for general corporate purposes, increasing near-term liquidity
- Additional debt creates repayment obligations and potentially greater financing risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other TuHURA Biosciences, Inc./NV 8-K filings
Get the next HURA 8-K as it lands
Follow HURA for push alerts, or ask the research agent what this filing means.